tiprankstipranks
Trending News
More News >
Altimmune Inc (ALT)
NASDAQ:ALT
US Market

Altimmune (ALT) Income Statement

Compare
3,518 Followers

Altimmune Income Statement

Last quarter (Q3 2025), Altimmune's total revenue was $5.00K, a decrease of 0.00% from the same quarter last year. In Q3, Altimmune's net income was $-19.01M. See Altimmune’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 20.00K$ 426.00K$ -68.00K$ 4.41M$ 8.19M
Gross Profit
$ 20.00K$ 426.00K$ -68.00K$ 4.41M$ -25.32M
Operating Expenses
$ 103.19M$ 96.36M$ 87.67M$ 101.32M$ 29.47M
Depreciation and Amortization
$ 238.00K$ 477.00K$ 493.00K$ 551.00K$ 428.88K
EBITDA
$ -94.81M$ -87.94M$ -84.41M$ -96.53M$ -38.10M
Operating Income
$ -103.17M$ -95.93M$ -87.74M$ -96.91M$ -54.80M
Other Income/Expenses
$ 8.11M$ 7.48M$ 2.83M$ -176.00K$ 11.17M
Pretax Income
$ -95.06M$ -88.45M$ -84.91M$ -97.09M$ -43.63M
Net Income
$ -95.06M$ -88.45M$ -84.71M$ -97.09M$ -49.04M
Per Share Metrics
Basic EPS
$ -1.34$ -1.66$ -1.81$ -2.35$ -1.91
Diluted EPS
$ -1.34$ -1.66$ -1.81$ -2.35$ -1.91
Weighted Average Shares Outstanding
71.00M 53.25M 46.93M 41.28M 25.64M
Weighted Average Shares Outstanding (Diluted)
71.00M 53.25M 46.93M 41.28M 25.64M
Currency in USD

Altimmune Earnings and Revenue History